Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

2OVY

Crystal structure of the catalytic domain of rat phosphodiesterase 10A

Summary for 2OVY
Entry DOI10.2210/pdb2ovy/pdb
Related2O8H 2OVV
DescriptorPhosphodiesterase-10A, SULFATE ION, ZINC ION, ... (6 entities in total)
Functional Keywordsphosphodiesterase 10a; zn-binding site, hydrolase
Biological sourceRattus norvegicus (Norway rat)
Cellular locationCytoplasm : Q9QYJ6
Total number of polymer chains1
Total formula weight42250.93
Authors
Pandit, J.,Marr, E.S. (deposition date: 2007-02-15, release date: 2007-03-06, Last modification date: 2024-02-21)
Primary citationChappie, T.A.,Humphrey, J.M.,Allen, M.P.,Estep, K.G.,Fox, C.B.,Lebel, L.A.,Liras, S.,Marr, E.S.,Menniti, F.S.,Pandit, J.,Schmidt, C.J.,Tu, M.,Williams, R.D.,Yang, F.V.
Discovery of a series of 6,7-dimethoxy-4-pyrrolidylquinazoline PDE10A inhibitors
J.Med.Chem., 50:182-185, 2007
Cited by
PubMed Abstract: A papaverine based pharmacophore model for PDE10A inhibition was generated via SBDD and used to design a library of 4-amino-6,7-dimethoxyquinazolines. From this library emerged an aryl ether pyrrolidyl 6,7-dimethoxyquinazoline series that became the focal point for additional modeling, X-ray, and synthetic efforts toward increasing PDE10A inhibitory potency and selectivity versus PDE3A/B. These efforts culminated in the discovery of 29, a potent and selective brain penetrable inhibitor of PDE10A.
PubMed: 17228859
DOI: 10.1021/jm060653b
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.8 Å)
Structure validation

237735

数据于2025-06-18公开中

PDB statisticsPDBj update infoContact PDBjnumon